BCL2 and endometrial cancer: miR-204 is reported to act as a tumor suppressor in a variety of cancers through different mechanisms including down-regulation of Bcl-2, NTRK2 in neuroblastoma cancer and suppression of invasion in endometrial cancer mediated by FOXC1 regulation[31,32].